566 related articles for article (PubMed ID: 33031846)
1. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
Kim TH; Koh YH; Kim BH; Kim MJ; Lee JH; Park B; Park JW
J Hepatol; 2021 Mar; 74(3):603-612. PubMed ID: 33031846
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.
Kim N; Cheng J; Jung I; Liang J; Shih YL; Huang WY; Kimura T; Lee VHF; Zeng ZC; Zhenggan R; Kay CS; Heo SJ; Won JY; Seong J
J Hepatol; 2020 Jul; 73(1):121-129. PubMed ID: 32165253
[TBL] [Abstract][Full Text] [Related]
4. Longer Survival and Preserved Liver Function after Proton Beam Therapy for Patients with Unresectable Hepatocellular Carcinoma.
Nosaka T; Matsuda H; Sugata R; Akazawa Y; Takahashi K; Naito T; Ohtani M; Kinoshita K; Tsujikawa T; Sato Y; Maeda Y; Tamamura H; Nakamoto Y
Curr Oncol; 2023 Mar; 30(4):3915-3926. PubMed ID: 37185409
[TBL] [Abstract][Full Text] [Related]
5. The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period.
Tanaka T; Takata K; Kunimoto H; Fukuda H; Yamauchi R; Tsuchiya N; Inomata S; Yokoyama K; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
Oncology; 2020; 98(12):859-868. PubMed ID: 32799203
[TBL] [Abstract][Full Text] [Related]
6. Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis.
Sekino Y; Tateishi R; Fukumitsu N; Okumura T; Maruo K; Iizumi T; Numajiri H; Mizumoto M; Minami T; Nakagomi R; Sato M; Asaoka Y; Nakagawa H; Hayata Y; Fujiwara N; Shiina S; Koike K; Sakurai H
Liver Cancer; 2023 Sep; 12(4):297-308. PubMed ID: 37817755
[TBL] [Abstract][Full Text] [Related]
7. Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial.
Xia Y; Li J; Liu G; Wang K; Qian G; Lu Z; Yang T; Yan Z; Lei Z; Si A; Wan X; Zhang H; Gao C; Cheng Z; Pawlik TM; Wang H; Lau WY; Wu M; Shen F
JAMA Oncol; 2020 Feb; 6(2):255-263. PubMed ID: 31774468
[TBL] [Abstract][Full Text] [Related]
8. Iodine-125 Brachytherapy Can Prolong Progression-Free Survival of Patients with Locoregional Recurrence and/or Residual Hepatocellular Carcinoma After Radiofrequency Ablation.
Chen L; Ying X; Zhang D; Lai L; Wu F; Tu J; Ji J
Cancer Biother Radiopharm; 2021 Dec; 36(10):820-826. PubMed ID: 32551979
[No Abstract] [Full Text] [Related]
9. Radiofrequency Ablation Using a Separable Clustered Electrode for the Treatment of Hepatocellular Carcinomas: A Randomized Controlled Trial of a Dual-Switching Monopolar Mode Versus a Single-Switching Monopolar Mode.
Choi JW; Lee JM; Lee DH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Cho EJ
Korean J Radiol; 2021 Feb; 22(2):179-188. PubMed ID: 32729269
[TBL] [Abstract][Full Text] [Related]
10. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
[TBL] [Abstract][Full Text] [Related]
12. Combined image-guided radiofrequency and iodine-125 seeds implantation in the treatment of recurrent hepatocellular carcinoma after hepatectomy.
Cao F; Zheng J; Hao W
BMC Cancer; 2024 May; 24(1):666. PubMed ID: 38822264
[TBL] [Abstract][Full Text] [Related]
13. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation versus hepatic resection for recurrent hepatocellular carcinoma: an updated meta-analysis.
Yang D; Zhuang B; Wang Y; Xie X; Xie X
BMC Gastroenterol; 2020 Nov; 20(1):402. PubMed ID: 33246417
[TBL] [Abstract][Full Text] [Related]
15. Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis.
Rim CH; Lee JS; Kim SY; Seong J
JHEP Rep; 2023 Jan; 5(1):100594. PubMed ID: 36561128
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma.
Kim N; Kim HJ; Won JY; Kim DY; Han KH; Jung I; Seong J
Radiother Oncol; 2019 Feb; 131():81-87. PubMed ID: 30773192
[TBL] [Abstract][Full Text] [Related]
17. Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial.
Lee DH; Lee MW; Kim PN; Lee YJ; Park HS; Lee JM
Radiology; 2021 Oct; 301(1):229-236. PubMed ID: 34313474
[TBL] [Abstract][Full Text] [Related]
18. Acetic acid versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A randomized controlled trial.
Paul SB; Acharya SK; Gamanagatti SR; Sreenivas V; Shalimar S; Gulati MS
Diagn Interv Imaging; 2020 Feb; 101(2):101-110. PubMed ID: 31302075
[TBL] [Abstract][Full Text] [Related]
19. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
[TBL] [Abstract][Full Text] [Related]
20. Surgical resection versus radiofrequency ablation very early-stage HCC (≤2 cm Single HCC): A propensity score analysis.
Chu HH; Kim JH; Kim PN; Kim SY; Lim YS; Park SH; Ko HK; Lee SG
Liver Int; 2019 Dec; 39(12):2397-2407. PubMed ID: 31549771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
